VISCONTI, ROBERTA
 Distribuzione geografica
Continente #
AS - Asia 1.287
NA - Nord America 910
EU - Europa 409
SA - Sud America 226
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 26
Totale 2.908
Nazione #
US - Stati Uniti d'America 860
SG - Singapore 528
CN - Cina 293
BR - Brasile 183
IT - Italia 163
VN - Vietnam 143
HK - Hong Kong 135
FR - Francia 78
KR - Corea 62
DE - Germania 44
NL - Olanda 28
BD - Bangladesh 20
GB - Regno Unito 20
JP - Giappone 20
CA - Canada 18
AT - Austria 17
FI - Finlandia 16
AR - Argentina 15
ID - Indonesia 15
IN - India 13
MX - Messico 13
IL - Israele 11
EC - Ecuador 10
IQ - Iraq 10
ZA - Sudafrica 8
CO - Colombia 7
MA - Marocco 7
KZ - Kazakistan 5
MY - Malesia 5
PK - Pakistan 5
PL - Polonia 5
RU - Federazione Russa 5
CR - Costa Rica 4
ES - Italia 4
GT - Guatemala 4
KE - Kenya 4
TR - Turchia 4
UA - Ucraina 4
VE - Venezuela 4
AL - Albania 3
HN - Honduras 3
IE - Irlanda 3
PE - Perù 3
BN - Brunei Darussalam 2
CL - Cile 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
SE - Svezia 2
SV - El Salvador 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 2.859
Città #
Santa Clara 292
Singapore 291
Hong Kong 134
Hefei 126
San Jose 92
Lauterbourg 65
Ashburn 63
Seoul 62
Ho Chi Minh City 55
Beijing 46
Hanoi 34
Naples 33
Los Angeles 22
São Paulo 18
New York 15
Helsinki 13
Atlanta 12
Frankfurt am Main 12
Milan 12
Nuremberg 12
Rome 12
Council Bluffs 11
Dallas 11
Minamishinagawa 10
Buffalo 9
Falkenstein 9
Tokyo 8
Vienna 8
Bengaluru 7
Da Nang 7
Chicago 6
Dhaka 6
Quito 6
Rio de Janeiro 6
Toronto 6
Belo Horizonte 5
Florence 5
Newark 5
Bạc Liêu 4
Charlotte 4
Haiphong 4
Hải Dương 4
Jakarta 4
Philadelphia 4
Phoenix 4
Warsaw 4
Bologna 3
Campinas 3
Campo Novo do Parecis 3
Johannesburg 3
Kuala Lumpur 3
Marigliano 3
Montreal 3
Munich 3
Nairobi 3
Ninh Bình 3
Paternò 3
Porto Alegre 3
Portsmouth 3
Quận Năm 3
San José 3
Springfield 3
St Louis 3
Tel Aviv 3
Thái Bình 3
Tirana 3
Venice 3
Almaty 2
Amsterdam 2
Baltimore 2
Bandar Seri Begawan 2
Bari 2
Basra 2
Bend 2
Boston 2
Brooklyn 2
Bến Cầu 2
Caracas 2
Cariacica 2
Casablanca 2
Caserta 2
Chesapeake 2
Cimitile 2
Cleveland 2
Contagem 2
Cordova 2
Cuiabá 2
Córdoba 2
Dublin 2
Duluth 2
Duque de Caxias 2
Düsseldorf 2
East Chicago 2
El Cajon 2
Esmeraldas 2
Guarulhos 2
Guatemala City 2
Guayaquil 2
Houston 2
Huế 2
Totale 1.707
Nome #
Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth 122
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 92
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology 80
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma 79
The between now and then of lung cancer chemotherapy and immunotherapy 77
Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword 72
The end of mitosis from a phosphatase perspective 67
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer 65
A rare adult primary intracranial sarcoma, DICER1-mutant identified by epigenomic profiling: a case report 61
Signaling by Type I and II cytokine receptors: ten years after 60
Wee1 rather than plk1 is inhibited by AZD1775 at therapeutically relevant concentrations 60
Looking beyond the glioblastoma mask: is genomics the right path? 58
Methylome profiling in Fabry disease in clinical practice: a proof of concept 58
Host fecal DNA specific methylation signatures mark gut dysbiosis and inflammation in children affected by autism spectrum disorder 56
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 56
Positive effects of glucocorticoids on T cell function and development by upregulation of interleukin-7 receptor alpha 53
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment 53
MGMT and whole-genome DNA methylation impacts on diagnosis, prognosis and therapy of glioblastoma multiforme 53
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane 52
Evaluation of MGMT gene methylation in neuroendocrine neoplasms 50
Fighting tubulin-targeting anticancer drug toxicity and resistance 48
Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression 46
Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance 46
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 46
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment. 46
Ret-mediated mitogenesis requires Src kinase activity 45
Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues 43
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. 42
Fcp-1 dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit 39
Characterization and analysis of the proximal Janus kinase 3 promoter 39
Overexpression of the HIP gene coding for a Heparin/Heparan Sulfate-binding protein in human thyroid carcinomas 37
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 37
The suppression of thyroid cell transformation by inhibition of HMGI-C protein synthesis is associated with changes in the AP-1 activity. 35
Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1 34
Janus kinases and STAT family transcription factors: their role in the function and development of lymphoid cells 33
The adapter molecule Gab2 is induced by lymphocyte activation and is involved in signaling by IL-2 and IL-15 but not other common gamma chain-using cytokines 33
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 33
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive 33
RET/PTC oncogene activation is an early event in thyroid carcinogenesis 32
New insights on oxidative stress in cancer 32
Sustaining the spindle assembly checkpoint to improve cancer therapy 32
Molecular basis of severe combined immunodeficiency: lessons from cytokine signaling pathways 32
Different mutations of the RET gene cause different human tumoral diseases 32
Inhibition of Th1 immune response by glucocorticoids: Dexamethasone inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes 31
Jaks and Stats as therapeutic targets 31
Role of thrombin receptor (Par-1) molecular variant in the occurrence of coronary artery disease in hypertensive patients 31
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 30
Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity 30
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. 30
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 30
The Platelet-derived Growth Factor Controls c-myc Expression through a JNK- and AP-1-dependent Signaling Pathway 29
Functional cloning of genes regulating apoptosis in neuronal cells 29
Glial cell line-Derived Neurotrophic Factor differentially stimulates Ret mutants associated with the Multiple Endocrine Neoplasia type 2 syndromes and Hirschsprung's disease 29
STAT4 serine phosphorylation is critical for IL-12-induced IFN-? production but not for cell proliferation 29
Importance of the MKK6-p38 pathway for IL-12-induced Stat4 serine phosphorylation and transcriptional activity 28
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation 28
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways 28
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression 27
The docking molecule Gab2 is induced by lymphocyte activation and is involved in signaling by Interleukin-2 and Interleukin-15 but not other common gamma chain-using cytokines 27
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 27
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenic mechanism of multiple endocrine neoplasia type 2B 27
The transcription factor Ets-1 is essential for janus kinase 3 (Jak3) promoter activity 26
Molecular biology of the MEN2 gene 26
Type I IFNs and regulation of Th1 responses: enigmas both resolved and emerge 25
A proximal promoter of Janus kinase 3 (Jak3) contains essential AP-1 and Ets-1 elements and is stimulated by T cell activation 24
STAT4 serine phosphorylation is critical for IL-12 induced IFN-gamma production and Th1 differentiation 24
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients 23
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor alpha 22
Analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients 18
Totale 2.908
Categoria #
all - tutte 9.791
article - articoli 9.333
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 347
Totale 19.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 1 0 20 1
2024/20251.058 11 3 70 31 257 57 19 62 27 67 249 205
2025/20261.503 90 155 131 194 272 44 209 69 58 182 68 31
2026/2027325 73 69 183 0 0 0 0 0 0 0 0 0
Totale 2.908